
August 16, 2014	Web Version \| Share with a colleague \| eNews Subscribe	You are subscribed to the FormularyWatch eNews

Study: Hep C drugs could increase Medicare Part D spending in 2015

The cost of Medicare Part D will increase significantly if new drugs such as Sovaldi and Olysio are used and the cost remains at the current level.
» Read more about Hep C drugs and Medicare Part D

FDA approves first fixed-dose treatment for type 2 diabetes

FDA has approved canagliflozin/metformin (Invokamet, Janssen), the first fixed-dose combination in the class of sodium glucose co-transporter 2 (SGLT2) inhibitors for the treatment of adults with type 2 diabetes.
» Read more on the newest diabetes drug

#icymi